Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

rifampicin-resistant tuberculosis (RR-TB) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

rifampicin-resistant tuberculosis

MONDO:0100479

Also known as:RR-TBrifampicin-resistant TB

Find Clinical TrialsTrials

Overview

A form of drug-resistant tuberculosis that is resisant to rifampicin with or without resistance to other antitubercular medications.

Clinical Trials7 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for rifampicin-resistant tuberculosis has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

7 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE4, 2 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT07268664](https://clinicaltrials.gov/study/NCT07268664)

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:02 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 7 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Disease patterns and progression	66	38%
Clinical study results	46	26%
Laboratory research	21	12%
Research summaries	14	8%
Testing and diagnosis research	13	7%
Patient case studies	6	3%
Other research	4	2%
New treatment approaches	4	2%

rifampicin-resistant tuberculosis

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications